SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?


To: arnie h who wrote (718)4/23/1999 11:16:00 AM
From: yosi s  Read Replies (2) | Respond to of 1386
 
Tamoxiphen analog is at preclinical stage at this point.
Pharmos stated that they may start clinical trial phase 1 later this year.
As for the time look how long it took Alrex and Lotemax and how long it took HU 211 to get to Phase 2 .
Tamoxiphene analog studies may move a little faster.



To: arnie h who wrote (718)4/23/1999 8:01:00 PM
From: Ron  Respond to of 1386
 
Arnie...thanks for the post. I am learning the "pitfalls" as I post....lol. Take care all. RON